Here, we reported that DCA treatment induced CAB39 expression through its direct target miR-107 and subsequently modulated the activities of AMPK/mTOR signal pathway, which is involved in overcoming CRC chemoresistance to L-OHP. This evidence concerns the gene CAB39 and colorectal carcinoma.